These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32655538)

  • 1. Challenging the Role of Diet-Induced Anti-Neu5Gc Antibodies in Human Pathologies.
    Soulillou JP; Cozzi E; Bach JM
    Front Immunol; 2020; 11():834. PubMed ID: 32655538
    [No Abstract]   [Full Text] [Related]  

  • 2. Why does multiple sclerosis only affect human primates?
    't Hart BA
    Mult Scler; 2016 Apr; 22(4):559-63. PubMed ID: 26540733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.
    Padler-Karavani V; Yu H; Cao H; Chokhawala H; Karp F; Varki N; Chen X; Varki A
    Glycobiology; 2008 Oct; 18(10):818-30. PubMed ID: 18669916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.
    Gao B; Long C; Lee W; Zhang Z; Gao X; Landsittel D; Ezzelarab M; Ayares D; Huang Y; Cooper DKC; Wang Y; Hara H
    PLoS One; 2017; 12(7):e0180768. PubMed ID: 28715486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation.
    Salama A; Evanno G; Harb J; Soulillou JP
    Xenotransplantation; 2015; 22(2):85-94. PubMed ID: 25308416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual selection by female immunity against paternal antigens can fix loss of function alleles.
    Ghaderi D; Springer SA; Ma F; Cohen M; Secrest P; Taylor RE; Varki A; Gagneux P
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17743-8. PubMed ID: 21987817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease.
    Padler-Karavani V; Tremoulet AH; Yu H; Chen X; Burns JC; Varki A
    PLoS One; 2013; 8(3):e58443. PubMed ID: 23520510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and qualitative changes in anti-Neu5Gc antibody response following rabbit anti-thymocyte IgG induction in kidney allograft recipients.
    Rousse J; Salama A; Leviatan Ben-Arye S; Hruba P; Slatinska J; Evanno G; Duvaux O; Blanchard D; Yu H; Chen X; Bach JM; Padler-Karavani V; Viklicky O; Soulillou JP
    Eur J Clin Invest; 2019 Apr; 49(4):e13069. PubMed ID: 30620396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States.
    Soulillou JP; Padler-Karavani V
    Front Immunol; 2020; 11():1589. PubMed ID: 32793227
    [No Abstract]   [Full Text] [Related]  

  • 10. Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?
    Obukhova P; Tsygankova S; Chinarev A; Shilova N; Nokel A; Kosma P; Bovin N
    Glycobiology; 2020 May; 30(6):395-406. PubMed ID: 31897477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.
    Hedlund M; Padler-Karavani V; Varki NM; Varki A
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18936-41. PubMed ID: 19017806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of Children to Rural Lifestyle Factors Associated With Protection Against Allergies Induces an Anti-Neu5Gc Antibody Response.
    Frei R; Roduit C; Ferstl R; O'Mahony L; Lauener RP
    Front Immunol; 2019; 10():1628. PubMed ID: 31379833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
    Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
    Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.
    Okerblom J; Varki A
    Chembiochem; 2017 Jul; 18(13):1155-1171. PubMed ID: 28423240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective.
    Altman MO; Gagneux P
    Front Immunol; 2019; 10():789. PubMed ID: 31134048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
    Yehuda S; Padler-Karavani V
    Front Immunol; 2020; 11():21. PubMed ID: 32038661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies.
    Basnet NB; Ide K; Tahara H; Tanaka Y; Ohdan H
    Xenotransplantation; 2010; 17(6):440-8. PubMed ID: 21158945
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Perota A; Galli C
    Front Immunol; 2019; 10():2396. PubMed ID: 31681287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antibody reactivity against xenogeneic N-glycolylneuraminic acid and galactose-α-1,3-galactose antigen.
    Hurh S; Kang B; Choi I; Cho B; Lee EM; Kim H; Kim YJ; Chung YS; Jeong JC; Hwang JI; Kim JY; Lee BC; Surh CD; Yang J; Ahn C
    Xenotransplantation; 2016 Jul; 23(4):279-92. PubMed ID: 27373998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum.
    Zhu A; Hurst R
    Xenotransplantation; 2002 Nov; 9(6):376-81. PubMed ID: 12371933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.